seattle semaglutide clinic Weight Loss Program & Tacoma Semaglutide Weight Loss Program Seattle

Taking semaglutide did not increase risk of depressive symptoms or suicidal behavior in persons without known major mental health disorders in a new study.

Inquire for COA & pricing.

Same active ingredient, different product, different FDA standing a clear, physician-reviewed answer on compounded semaglutide vs Ozempic, when compounding is permitted, and how to source it safely.

This article reviews trends related to GLP-1-type pharmaceuticals and discusses considerations for fill-and-finish and primary packaging containers

Or, call (954) 738-5886 to schedule your appointment

Semaglutide is a GLP-1 analogue with 94% sequence homology to human GLP-1. Semaglutide acts as a GLP-1 receptor agonist that selectively binds to and activates the GLP-1 receptor, the target for native GLP-1. GLP-1 is a physiological hormone that has multiple actions on glucose, mediated by the GLP-1 receptors. The principal mechanism of protraction resulting in the long half-life of semaglutide is albumin binding, which results in decreased renal clearance and protection from metabolic degradation. Furthermore, semaglutide is stabilized against degradation by the DPP-4 enzyme. Semaglutide reduces blood glucose through a mechanism where it stimulates insulin secretion and lowers glucagon secretion, both in a glucose-dependent manner. Thus, when blood glucose is high, insulin secretion is stimulated and glucagon secretion is inhibited. The mechanism of blood glucose lowering also involves a minor delay in gastric emptying in the early postprandial phase